Corporate Tech Investors

Inovio Pharmaceuticals

Inovio Pharmaceuticals is a corporate VC investing group that partners with technologies that align with its strategic interests.

Venture Investor Overview

Contact Information

Background Information

Overview

Inovio is bringing IMMUNO-INGENUITY to life and is reshaping the future of treating and preventing cancer and infectious diseases. Inovio's technology platform is capable of activating antigen-specific immune responses. With demonstrated efficacy in a Phase 2b trial, robust and targeted immune responses, a favorable safety profile, and a robust pipeline of product candidates across multiple disease states, the evidence to date is clear--Inovio is realizing the true promise of immunotherapy.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/25/2022

Transaction History

Our records indicate that Inovio Pharmaceuticals invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Joseph Kim

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Inovio Pharmaceuticals has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Inova Health System | InsideView

Share this article

About Our Corporate Tech Investor Database

This corporate tech investment data comes via a partnership with VentureDeal.com, a market leader in strategic investor transaction data for corporations that invest in the tech sector.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary